Danshen Chuanxiongzin Injection, the main ingredients of which are Danshen and Chuanxiongzin hydrochloride, can be used in clinical practice to treat coronary atherosclerotic heart disease, angina pectoris, myocardial infarction, as well as ischemic stroke and thromboembolic vasculitis, and is relatively a broad-spectrum circulatory improvement drug with significant effects. It is generally recommended that patients can choose intravenous drip, each time with 5-10ml, generally about 7-10 days for a treatment cycle, in the process of applying this drug, it is not recommended to drip too fast, for patients with diabetes should be careful to use this drug, there are patients with cerebral hemorrhage or bleeding tendency, to prohibit this drug.